SCHEMBL7422102

SCHEMBL7422102

CN(C)CCCNC(=S)NCCCN(Cc1ccc(Br)cc1)c1ccccn1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR4 P31391 10/20 0.76
SSTR2 P30874 7/20 0.70
GBA1 P04062 5/20 0.55
RAD52 P43351 1/20 0.55
CHRM2 P08172 3/20 0.53
ADRA2A P08913 3/20 0.53
DRD1 P21728 3/20 0.53
SLC6A4 P31645 3/20 0.53
SLC6A3 Q01959 3/20 0.53
KCNH2 Q12809 3/20 0.53
SLC6A2 P23975 2/20 0.53
ADRA1A P35348 2/20 0.53
HTR2A P28223 2/20 0.53
HRH1 P35367 2/20 0.53
ADRA2B P18089 1/20 0.53
ADRA2C P18825 1/20 0.53
OPRK1 P41145 1/20 0.53
KDM4E B2RXH2 2/20 0.52
LMNA P02545 2/20 0.52
CYP1A2 P05177 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethylamine SCHEMBL7422105 0.90 SSTR4 (0.74) SSTR4SSTR2GBA1RAD52
SCHEMBL7421638 0.86 SSTR4 (0.58) SSTR4SSTR2GBA1CHRM2ADRA2A
SCHEMBL7421851 0.83 SSTR4 (1.00) SSTR4SSTR2GBA1RAD52
SCHEMBL7421016 0.83 SSTR4 (0.71) SSTR4SSTR2GBA1RAD52ADRA2A
Bromide SCHEMBL7424764 0.82 SSTR4 (0.98) SSTR4SSTR2GBA1RAD52
SCHEMBL7429342 0.82 SSTR4 (0.68) SSTR4SSTR2GBA1RAD52MEN1
Hydrochloric Acid SCHEMBL7423801 0.82 SSTR4 (0.70) SSTR4SSTR2GBA1RAD52ADRA2A
SCHEMBL8386885 0.81 CHRM2 (0.78) SSTR4CHRM2ADRA2ADRD1SLC6A4
SCHEMBL7421605 0.80 SSTR4 (1.00) SSTR4SSTR2GBA1RAD52
SCHEMBL7426650 0.78 SSTR4 (0.66) SSTR4SSTR2GBA1RAD52ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1019050-B1 USE OF SOMATOSTATIN AGONISTS AND ANTAGONISTS FOR TREATING DISEASES RELATED TO THE EYE NOVO NORDISK AS (DK) 2002-03-20 EP claimed
US-6159941-A Use of somatostatin agonists and antagonists for treating diseases related to the eye NOVO NORDISK A/S (DK) 2000-12-12 US claimed
US-6127343-A SELECTIVE, COMPETITIVE SOMATOSTATIN RECEPTOR LIGANDS OF NONPEPTIDE ORIGIN, FOR MEDIATING THE BIOLOGICAL EFFECT OF SOMATOSTATIN AGONISTS OR ANTAGONIST NOVO NORDISK A/S (DK) 2000-10-03 US claimed
EP-1019050-A1 USE OF SOMATOSTATIN AGONISTS AND ANTAGONISTS FOR TREATING DISEASES RELATED TO THE EYE NOVO NORDISK A/S (DK) 2000-07-19 EP claimed
EP-0912551-A1 SOMATOSTATIN AGONISTS AND ANTAGONISTS NOVO NORDISK A/S (DK) 1999-05-06 EP claimed
WO-1998058646-A1 USE OF SOMATOSTATIN AGONISTS AND ANTAGONISTS FOR TREATING DISEASES RELATED TO THE EYE NOVO NORDISK A/S (DK) 1998-12-30 WO claimed
WO-1997043278-A1 SOMATOSTATIN AGONISTS AND ANTAGONISTS NOVO NORDISK A/S (DK) 1997-11-20 WO claimed
EP-1019050-B1 USE OF SOMATOSTATIN AGONISTS AND ANTAGONISTS FOR TREATING DISEASES RELATED TO THE EYE NOVO NORDISK AS (DK) 2002-03-20 EP disclosed
US-6159941-A Use of somatostatin agonists and antagonists for treating diseases related to the eye NOVO NORDISK A/S (DK) 2000-12-12 US disclosed
US-6127343-A SELECTIVE, COMPETITIVE SOMATOSTATIN RECEPTOR LIGANDS OF NONPEPTIDE ORIGIN, FOR MEDIATING THE BIOLOGICAL EFFECT OF SOMATOSTATIN AGONISTS OR ANTAGONIST NOVO NORDISK A/S (DK) 2000-10-03 US disclosed
EP-1019050-A1 USE OF SOMATOSTATIN AGONISTS AND ANTAGONISTS FOR TREATING DISEASES RELATED TO THE EYE NOVO NORDISK A/S (DK) 2000-07-19 EP disclosed
EP-0912551-A1 SOMATOSTATIN AGONISTS AND ANTAGONISTS NOVO NORDISK A/S (DK) 1999-05-06 EP disclosed
WO-1998058646-A1 USE OF SOMATOSTATIN AGONISTS AND ANTAGONISTS FOR TREATING DISEASES RELATED TO THE EYE NOVO NORDISK A/S (DK) 1998-12-30 WO disclosed
WO-1997043278-A1 SOMATOSTATIN AGONISTS AND ANTAGONISTS NOVO NORDISK A/S (DK) 1997-11-20 WO disclosed